218 related articles for article (PubMed ID: 31839604)
21. Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.
Hoshino I; Nagata M; Takiguchi N; Nabeya Y; Ikeda A; Yokoi S; Kuwajima A; Tagawa M; Matsushita K; Satoshi Y; Hideaki S
Cancer Sci; 2017 Mar; 108(3):308-315. PubMed ID: 28064445
[TBL] [Abstract][Full Text] [Related]
22. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.
Liu X; Chai Y; Li J; Ren P; Liu M; Dai L; Qian W; Li W; Zhang JY
Tumour Biol; 2014 Mar; 35(3):2661-7. PubMed ID: 24399648
[TBL] [Abstract][Full Text] [Related]
23. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
[TBL] [Abstract][Full Text] [Related]
25. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.
Ye H; Sun C; Ren P; Dai L; Peng B; Wang K; Qian W; Zhang J
Oncol Lett; 2013 Feb; 5(2):663-668. PubMed ID: 23420714
[TBL] [Abstract][Full Text] [Related]
26. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY
J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838
[TBL] [Abstract][Full Text] [Related]
27. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
[TBL] [Abstract][Full Text] [Related]
28. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E
Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679
[TBL] [Abstract][Full Text] [Related]
29. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
[TBL] [Abstract][Full Text] [Related]
31. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract][Full Text] [Related]
32. Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer.
Sumazaki M; Ogata H; Nabeya Y; Kuwajima A; Hiwasa T; Shimada H
Cancer Sci; 2021 May; 112(5):1955-1962. PubMed ID: 33605508
[TBL] [Abstract][Full Text] [Related]
33. Multi-panel assay of serum autoantibodies in colorectal cancer.
Ushigome M; Nabeya Y; Soda H; Takiguchi N; Kuwajima A; Tagawa M; Matsushita K; Koike J; Funahashi K; Shimada H
Int J Clin Oncol; 2018 Oct; 23(5):917-923. PubMed ID: 29691673
[TBL] [Abstract][Full Text] [Related]
34. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
[TBL] [Abstract][Full Text] [Related]
36. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients.
Cressey R; Pimpa S; Chewaskulyong B; Lertprasertsuke N; Saeteng S; Tayapiwatana C; Kasinrerk W
BMC Biotechnol; 2008 Feb; 8():16. PubMed ID: 18284706
[TBL] [Abstract][Full Text] [Related]
37. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of humoral immune responses against tumor antigens.
Reuschenbach M; von Knebel Doeberitz M; Wentzensen N
Cancer Immunol Immunother; 2009 Oct; 58(10):1535-44. PubMed ID: 19562338
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies in breast cancer: their use as an aid to early diagnosis.
Chapman C; Murray A; Chakrabarti J; Thorpe A; Woolston C; Sahin U; Barnes A; Robertson J
Ann Oncol; 2007 May; 18(5):868-73. PubMed ID: 17347129
[TBL] [Abstract][Full Text] [Related]
40. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]